Volatility is a really important theme for natural gas, says EQT President and CEO Toby Rice
Volatility is a really important theme for natural gas, says EQT President and CEO Toby Rice
President and CEO Toby Rice joins 'Mad Money' host Jim Cramer to talk quarterly results, the energy sector and more.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Jim Cramer Says 'Under Pressure Are The Two Words We Hear Every Morning.' He Thinks That's Why Europe's Doing Better—But Not Everyone Agrees
CNBC's Jim Cramer sparked debate on Monday when he posted on X that the phrase 'under pressure' has become the morning routine in U.S. markets. 'No wonder Europe [is] doing better than we are,' he wrote. The following day, he doubled down, posting: 'I do not know when the market will NOT be under pressure in the morning. I think as long as Europe's markets are viewed as safer than ours it could be a constant.'Don't Miss:Invest where it hurts — and help millions heal:. Cramer's post drew plenty of pushback. One person wrote, 'Europe is absolutely not doing better than we are,' while another said, 'Short EU, Long USA.' One analyst offered a more nuanced take: 'EU is actually not doing better than the US economically or in tech/productivity, but they do now have lower government debt and higher quality of life.' Others took a more skeptical or sarcastic tone. 'Europe looks to be like a giant California. Which is falling apart,' one user replied. Another joked, 'Jim, we're about to crash. Need you to be bullish.' But the question of Europe outperforming isn't just about opinions online. Trending: Maximize saving for your retirement and cut down on taxes: . According to a recent Bloomberg report, eight of the world's 10 best-performing stock markets are in Europe. Germany's DAX Index is up more than 30% in dollar terms. Markets in countries like Poland, Slovenia, Hungary and Greece are also seeing double-digit growth. The pan-European Stoxx 600 Index is beating the S&P 500 by a record 18 percentage points this year. Bloomberg reports that the strong performance is being driven by Germany's massive infrastructure and defense spending plans, a stronger euro, and solid corporate earnings. 'Europe is back on the map,' head of investment strategy for RBC Wealth Management Frederique Carrier told Bloomberg. 'We are getting more questions about Europe now over the last two months than we did over the last 10 years.' UBS Group AG analysts estimate that $1.4 trillion could shift from U.S. assets into European equities over the next five expanded in a CNBC column on June 1 on why he thinks the U.S. market keeps getting dragged down. 'We keep getting thrown off, and the lack of predictability is driving investors elsewhere,' he said. He argued that while Europe may not be surging economically, its relative stability makes it attractive. 'Do we really think the economies in Europe are doing that well? Is Italy on fire? Spain soaring? No. But what they do have is consistency, even if it is the consistency of mediocrity. We, on the other hand, have no stability whatsoever because of the incredible, mind-boggling power of the White House.' Cramer pointed to what he calls a 'Trump discount' weighing on sectors like tech, retail, pharmaceuticals, and banking. 'We sit here, agog, as Europe goes higher when we have companies in our stock indexes that are doing much, much better than any of theirs. But it doesn't matter because ours can be taken away with a stroke of President Donald Trump's pen — and don't we know it.' Read Next: Can you guess how many retire with a $5,000,000 nest egg? .UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Jim Cramer Says 'Under Pressure Are The Two Words We Hear Every Morning.' He Thinks That's Why Europe's Doing Better—But Not Everyone Agrees originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
2 hours ago
- CNBC
Cramer says call between Trump and Xi 'could change everything you see' in market
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Thursday 's key moments. 1. The stock market dipped on Thursday following Wednesday's subdued session. Investors are bracing for trade updates following Chinese media reports of a phone call between President Donald Trump and President Xi Jinping. "What's at stake is higher than anything we see," Jim Cramer said. Though details of the call are unknown, China's strong hold on rare earth materials is now a hot topic. "Are they discussing the idea that maybe Nvidia will swap [chips] in order to get the rare minerals?" Jim said. "That call could change everything you see on screen." The White House has yet to confirm the call, according to CNBC. Interest rates are still lower after Wednesday's weak ADP report. If Friday's job report confirms the ADP stats, "the pressure at this time may be so great that they [the Fed] have to do something," Jim said. 2. Club name Costco is down a little more than 3%, after the retailer on Wednesday reported May sales growth cooled down from April and missed expectations. Global sales were up 4.3% year over year versus the 4.7% expected. Excluding foreign exchange and gas prices, sales increased 6% versus 6.2% expected. The stock has given back some gains since reporting earnings last week, but is still up 11.6% year to date. Jim has been a long time supporter of Costco, touting it as the go-to retailer in any economic environment. The Club is "not profit taking" when it comes to Costco, said Jeff Marks, director of portfolio analysis for the Club. 3. Broadcom reports after the closing bell Thursday and the stock is still on a run: up more than 7% this week and 10% in the past two weeks. The Club is not enthused over the set up into earnings. But we're expecting a strong ramp from its current AI customers Google and Meta , with some potential noise from Bytedance due to headlines out of China. The semiconductor manufacturer announced earlier this week that its now shipping out the Tomahawk 6 switch, which it says is better than any Ethernet on the market. 4 . Stocks covered in Thursday's rapid fire at the end of the video were: Visa , Chewy , Procter & Gamble , Five Below , and Brown-Forman . (Jim Cramer's Charitable Trust is long AVGO, COST. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Yahoo
9 hours ago
- Yahoo
Jim Cramer on Arrowhead Pharmaceuticals (ARWR): 'It Doesn't Make Any Money'
We recently published a list of . In this article, we are going to take a look at where Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) stands against other stocks that Jim Cramer discusses. When a caller inquired about Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), Cramer said: 'You know, look, it doesn't make any money. I've been waiting for it to do something, break out. I just don't know if it has the horses.' A scientist in a lab coat analyzing a Petri dish surrounded by scientific equipment in a research lab. Arrowhead Pharmaceuticals (NASDAQ:ARWR) develops RNA-based treatments for a wide range of hard-to-treat diseases, with multiple drug candidates in clinical trials targeting conditions such as cardiovascular disorders, liver disease, pulmonary illness, and rare genetic disorders. Additionally, in 2019, Cramer said the following about the company: 'I looked at Arrowhead recently and I didn't see that much. You know, everyone's so excited about it. I don't get that. I have been saying that it's absolutely O.K. to own stocks that have to do with slicing and dicing and genes, but I'm not gonna endorse it for anything other than speculation.' For context, since the above comment was aired, Arrowhead Pharmaceuticals (NASDAQ:ARWR) stock declined more than 75%. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
